Cargando…

Incidence and relative risk for developing cancers in women with gestational diabetes mellitus: a nationwide cohort study in Taiwan

OBJECTIVES: To evaluate the risk of developing cancers, particularly site-specific cancers, in women with gestational diabetes mellitus (GDM) in Taiwan. SETTING: The National Health Insurance Research Database (NHIRD) of Taiwan. PARTICIPANTS: This study was conducted using the nationwide data from 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Yun-Shing, Lin, Jr-Rung, Cheng, Bi-Hua, Ho, Cheng, Lin, Yung-Hsiang, Shen, Chien-Hen, Tsai, Ming-Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398720/
https://www.ncbi.nlm.nih.gov/pubmed/30796123
http://dx.doi.org/10.1136/bmjopen-2018-024583
_version_ 1783399629092552704
author Peng, Yun-Shing
Lin, Jr-Rung
Cheng, Bi-Hua
Ho, Cheng
Lin, Yung-Hsiang
Shen, Chien-Hen
Tsai, Ming-Hung
author_facet Peng, Yun-Shing
Lin, Jr-Rung
Cheng, Bi-Hua
Ho, Cheng
Lin, Yung-Hsiang
Shen, Chien-Hen
Tsai, Ming-Hung
author_sort Peng, Yun-Shing
collection PubMed
description OBJECTIVES: To evaluate the risk of developing cancers, particularly site-specific cancers, in women with gestational diabetes mellitus (GDM) in Taiwan. SETTING: The National Health Insurance Research Database (NHIRD) of Taiwan. PARTICIPANTS: This study was conducted using the nationwide data from 2000 to 2013. In total, 1 466 596 pregnant women with admission for delivery were identified. Subjects with GDM consisted of 47 373 women, while the non-exposed group consisted of 943 199 women without GDM. The participants were followed from the delivery date to the diagnosis of cancer, death, the last medical claim or the end of follow-up (31 December 2013), whichever came first. PRIMARY OUTCOME MEASURES: Patients with a new diagnosis of cancer (International Classification of Diseases, ninth edition, with clinical modification (ICD-9-CM codes 140–208)) recorded in NHIRD were identified. The risk of 11 major cancer types was assessed, including cancers of head and neck, digestive organs, lung and bronchus, bone and connective tissue, skin, breast, genital organs, urinary system, brain, thyroid gland and haematological system. RESULTS: The rates of developing cancers were significantly higher in women with GDM compared with the non-GDM group (2.24% vs 1.96%; p<0.001). After adjusting for maternal age at delivery and comorbidities, women with GDM had increased risk of cancers, including cancers of nasopharynx (adjusted HR, 1.739; 95 % CI, 1.400 to 2.161; p<0.0001), kidney (AHR, 2.169; 95 % CI, 1.428 to 3.293; p=0.0003), lung and bronchus (AHR, 1.372; 95 % CI, 1.044 to 1.803; p=0.0231), breast (AHR, 1.234; 95% CI, 1.093 to 1.393; p=0.007) and thyroid gland (AHR, 1.389; 95 % CI, 1.121 to 1.721; p=0.0026). CONCLUSION: Women with GDM have a higher risk of developing cancers. Cancer screening is warranted in women with GDM. Future research should be aimed at establishing whether this association is causal.
format Online
Article
Text
id pubmed-6398720
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-63987202019-03-20 Incidence and relative risk for developing cancers in women with gestational diabetes mellitus: a nationwide cohort study in Taiwan Peng, Yun-Shing Lin, Jr-Rung Cheng, Bi-Hua Ho, Cheng Lin, Yung-Hsiang Shen, Chien-Hen Tsai, Ming-Hung BMJ Open Diabetes and Endocrinology OBJECTIVES: To evaluate the risk of developing cancers, particularly site-specific cancers, in women with gestational diabetes mellitus (GDM) in Taiwan. SETTING: The National Health Insurance Research Database (NHIRD) of Taiwan. PARTICIPANTS: This study was conducted using the nationwide data from 2000 to 2013. In total, 1 466 596 pregnant women with admission for delivery were identified. Subjects with GDM consisted of 47 373 women, while the non-exposed group consisted of 943 199 women without GDM. The participants were followed from the delivery date to the diagnosis of cancer, death, the last medical claim or the end of follow-up (31 December 2013), whichever came first. PRIMARY OUTCOME MEASURES: Patients with a new diagnosis of cancer (International Classification of Diseases, ninth edition, with clinical modification (ICD-9-CM codes 140–208)) recorded in NHIRD were identified. The risk of 11 major cancer types was assessed, including cancers of head and neck, digestive organs, lung and bronchus, bone and connective tissue, skin, breast, genital organs, urinary system, brain, thyroid gland and haematological system. RESULTS: The rates of developing cancers were significantly higher in women with GDM compared with the non-GDM group (2.24% vs 1.96%; p<0.001). After adjusting for maternal age at delivery and comorbidities, women with GDM had increased risk of cancers, including cancers of nasopharynx (adjusted HR, 1.739; 95 % CI, 1.400 to 2.161; p<0.0001), kidney (AHR, 2.169; 95 % CI, 1.428 to 3.293; p=0.0003), lung and bronchus (AHR, 1.372; 95 % CI, 1.044 to 1.803; p=0.0231), breast (AHR, 1.234; 95% CI, 1.093 to 1.393; p=0.007) and thyroid gland (AHR, 1.389; 95 % CI, 1.121 to 1.721; p=0.0026). CONCLUSION: Women with GDM have a higher risk of developing cancers. Cancer screening is warranted in women with GDM. Future research should be aimed at establishing whether this association is causal. BMJ Publishing Group 2019-02-21 /pmc/articles/PMC6398720/ /pubmed/30796123 http://dx.doi.org/10.1136/bmjopen-2018-024583 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Diabetes and Endocrinology
Peng, Yun-Shing
Lin, Jr-Rung
Cheng, Bi-Hua
Ho, Cheng
Lin, Yung-Hsiang
Shen, Chien-Hen
Tsai, Ming-Hung
Incidence and relative risk for developing cancers in women with gestational diabetes mellitus: a nationwide cohort study in Taiwan
title Incidence and relative risk for developing cancers in women with gestational diabetes mellitus: a nationwide cohort study in Taiwan
title_full Incidence and relative risk for developing cancers in women with gestational diabetes mellitus: a nationwide cohort study in Taiwan
title_fullStr Incidence and relative risk for developing cancers in women with gestational diabetes mellitus: a nationwide cohort study in Taiwan
title_full_unstemmed Incidence and relative risk for developing cancers in women with gestational diabetes mellitus: a nationwide cohort study in Taiwan
title_short Incidence and relative risk for developing cancers in women with gestational diabetes mellitus: a nationwide cohort study in Taiwan
title_sort incidence and relative risk for developing cancers in women with gestational diabetes mellitus: a nationwide cohort study in taiwan
topic Diabetes and Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398720/
https://www.ncbi.nlm.nih.gov/pubmed/30796123
http://dx.doi.org/10.1136/bmjopen-2018-024583
work_keys_str_mv AT pengyunshing incidenceandrelativeriskfordevelopingcancersinwomenwithgestationaldiabetesmellitusanationwidecohortstudyintaiwan
AT linjrrung incidenceandrelativeriskfordevelopingcancersinwomenwithgestationaldiabetesmellitusanationwidecohortstudyintaiwan
AT chengbihua incidenceandrelativeriskfordevelopingcancersinwomenwithgestationaldiabetesmellitusanationwidecohortstudyintaiwan
AT hocheng incidenceandrelativeriskfordevelopingcancersinwomenwithgestationaldiabetesmellitusanationwidecohortstudyintaiwan
AT linyunghsiang incidenceandrelativeriskfordevelopingcancersinwomenwithgestationaldiabetesmellitusanationwidecohortstudyintaiwan
AT shenchienhen incidenceandrelativeriskfordevelopingcancersinwomenwithgestationaldiabetesmellitusanationwidecohortstudyintaiwan
AT tsaiminghung incidenceandrelativeriskfordevelopingcancersinwomenwithgestationaldiabetesmellitusanationwidecohortstudyintaiwan